Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 3 1 Phase 1/2 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 592 Neoplasms 296 Carcinoma, Non-Small-Cell Lung 284 Prostatic Neoplasms 266 Colorectal Neoplasms 213 Multiple Myeloma 181 Lung Neoplasms 149 Neoplasm Metastasis 139 Leukemia, Myeloid, Acute 125 Leukemia 120 Lymphoma 114 Lymphoma, Follicular 113 Stomach Neoplasms 105 Lymphoma, Non-Hodgkin 102 Colonic Neoplasms 98 Ovarian Neoplasms 96 Rectal Neoplasms 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 94 Uterine Cervical Neoplasms 93 Head and Neck Neoplasms 92 Leukemia, Lymphocytic, Chronic, B-Cell 91 Pain 90 Carcinoma, Hepatocellular 86 Pancreatic Neoplasms 81 Melanoma 78 Lymphoma, Large B-Cell, Diffuse 77 Papillomavirus Infections 68 Recurrence 66 Squamous Cell Carcinoma of Head and Neck 64 Parkinson Disease 4, Autosomal Dominant Lewy Body 62

Interventions

Nivolumab 1 Ipilimumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Various Advanced Cancer × Clear all

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡